HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ainsley Weston Selected Research

HLA-DPB1 antigen (HLA DPB1)

10/2012Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove.
6/2009Genetic determinants of sensitivity to beryllium in mice.
12/2005Immunogenetic factors in beryllium sensitization and chronic beryllium disease.
8/2004The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization.
11/2003Electrostatic potential on human leukocyte antigen: implications for putative mechanism of chronic beryllium disease.
3/2003HLA-DPB1 and chronic beryllium disease: a HuGE review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ainsley Weston Research Topics

Disease

14Berylliosis
04/2021 - 06/2002
6Breast Neoplasms (Breast Cancer)
11/2014 - 01/2002
5Neoplasms (Cancer)
03/2017 - 01/2002
5Lung Diseases (Lung Disease)
06/2015 - 03/2003
2Genetic Predisposition to Disease (Genetic Predisposition)
01/2016 - 11/2003
2Silicosis
06/2015 - 02/2015
2Carcinogenesis
11/2004 - 01/2002
1Sarcoidosis (Schaumann Disease)
04/2021
1Malignant Mesothelioma
03/2017
1Pneumoconiosis
06/2015
1Respiratory Insufficiency (Respiratory Failure)
02/2015
1Hypersensitivity (Allergy)
06/2009
1Inflammation (Inflammations)
03/2009
1Endometrial Neoplasms (Endometrial Cancer)
02/2009
1Pathologic Processes
02/2007
1Body Weight (Weight, Body)
02/2006
1Prostatic Neoplasms (Prostate Cancer)
11/2004
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
11/2004
1Occupational Diseases (Occupational Disease)
08/2004
1Disease Progression
03/2003

Drug/Important Bio-Agent (IBA)

13BerylliumIBA
04/2021 - 03/2003
6HLA-DPB1 antigen (HLA DPB1)IBA
10/2012 - 03/2003
3BESIBA
01/2016 - 07/2010
2Silicon Dioxide (Silica)FDA LinkGeneric
06/2015 - 02/2015
2Glutamic Acid (Glutamate)FDA Link
10/2012 - 03/2003
2HLA Antigens (Human Leukocyte Antigens)IBA
06/2009 - 11/2003
2TamoxifenFDA LinkGeneric
02/2009 - 02/2006
2Proteins (Proteins, Gene)FDA Link
07/2008 - 12/2005
2Genetic Markers (Genetic Marker)IBA
12/2005 - 06/2002
1MineralsIBA
03/2017
1AsbestosIBA
03/2017
1Oxidoreductases (Dehydrogenase)IBA
11/2014
1quinone (benzoquinone)IBA
11/2014
1Peptides (Polypeptides)IBA
10/2012
1Interleukin-9 (Interleukin 9)IBA
07/2010
1Interleukin-2 (IL2)IBA
07/2010
1InterleukinsIBA
07/2010
1Cytochrome P-450 CYP1A1 (CYP1A1)IBA
03/2009
1InterferonsIBA
03/2009
1Histocompatibility Antigens Class IIIBA
07/2008
1AT-308 (AT 308)IBA
04/2007
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2007
1DNA (Deoxyribonucleic Acid)IBA
02/2007
1Coloring Agents (Dyes)IBA
01/2007
1Hair Preparations (Cosmetics, Hair)IBA
01/2007
1DNA AdductsIBA
02/2006
1EnzymesIBA
02/2006
1AntibodiesIBA
12/2005
1Histone Deacetylases (Histone Deacetylase)IBA
03/2005
1Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
03/2005
1theasinensin AIBA
03/2005
1VorinostatFDA Link
03/2005
1trichostatin A (A 300)IBA
03/2005
1Histone Deacetylase InhibitorsIBA
03/2005
1Gonadal Steroid Hormones (Sex Hormones)IBA
11/2004
1Cytochrome P-450 CYP3AIBA
11/2004
1Biomarkers (Surrogate Marker)IBA
09/2004
1HLA-DP Antigens (HLA-DP)IBA
03/2003
1CarcinogensIBA
01/2003
1ORALIT (ORS)IBA
01/2002
1N 30IBA
01/2002

Therapy/Procedure

1Lung Transplantation
02/2015
1Secondary Prevention
01/2003